Donald E. Bobo Jr. is CVP & Strategy/Corp Development at Edwards Lifesciences Corp (EW). They have made 116 open-market trades across 1 company since 2009, most recently 2026-05-27.
CIK 0001196661
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 116 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| EW | 98,611 | $8.5M |
Shares reported on the most recent Form 4, priced at the 2026-05-27 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| EW | SELL | 2026-05-27 | 2026-05-27 | $86.42 | $2.0M | -0.8% | +4.9% | +5.0% |
| EW | SELL | 2026-05-15 | 2026-05-18 | $81.96 | $1.5M | +4.8% | +5.0% | +10.0% |
| EW | SELL · 10b5-1 | 2026-04-02 | 2026-04-02 | $80.16 | $1.8M | -3.5% | +2.9% | +13.6% |
| EW | SELL | 2026-03-02 | 2026-03-02 | $85.93 | $974K | -1.5% | -5.4% | +2.7% |
| EW | SELL | 2026-02-25 | 2026-02-26 | $83.84 | $2.0M | +0.0% | -7.3% | +0.9% |
| EW | SELL | 2026-01-06 | 2026-01-06 | $85.66 | $971K | -2.2% | -9.5% | -5.9% |
| EW | SELL | 2025-12-12 | 2025-12-12 | $83.76 | $1.9M | +3.3% | -0.7% | +1.2% |
| EW | SELL · 10b5-1 | 2025-12-10 | 2025-12-10 | $83.83 | $1.9M | +2.6% | +0.9% | +1.7% |
| EW | SELL · 10b5-1 | 2025-06-02 | 2025-06-02 | $77.40 | $398K | -1.9% | -0.5% | +5.7% |
| EW | SELL · 10b5-1 | 2025-04-14 | 2025-04-14 | $69.81 | $663K | +8.1% | +9.1% | +11.3% |
| EW | SELL · 10b5-1 | 2025-03-13 | 2025-03-13 | $67.96 | $1.3M | +4.1% | +2.1% | +10.3% |
| EW | SELL · 10b5-1 | 2025-02-13 | 2025-02-13 | $75.74 | $977K | -5.6% | -7.3% | +0.7% |
| EW | SELL · 10b5-1 | 2025-01-16 | 2025-01-16 | $68.75 | $344K | +1.7% | +8.2% | +1.8% |
| EW | SELL · 10b5-1 | 2024-12-09 | 2024-12-09 | $71.75 | $359K | +3.8% | +4.1% | -3.8% |
| EW | SELL · 10b5-1 | 2024-11-13 | 2024-11-13 | $65.57 | $656K | +7.4% | +10.4% | +6.8% |
| EW | SELL · 10b5-1 | 2024-10-15 | 2024-10-15 | $69.51 | $348K | +0.9% | -3.7% | +3.4% |
| EW | SELL · 10b5-1 | 2024-09-11 | 2024-09-11 | $66.77 | $334K | -1.1% | +0.0% | +7.8% |
| EW | SELL · 10b5-1 | 2024-08-14 | 2024-08-14 | $66.08 | $330K | +2.4% | +2.0% | -2.0% |
| EW | SELL · 10b5-1 | 2024-07-10 | 2024-07-10 | $93.29 | $933K | -6.6% | -31.4% | -27.2% |
| EW | SELL · 10b5-1 | 2024-06-12 | 2024-06-12 | $87.54 | $875K | +4.3% | +4.2% | -23.1% |
| EW | SELL · 10b5-1 | 2024-05-10 | 2024-05-13 | $87.81 | $439K | +1.9% | +2.2% | -23.6% |
| EW | SELL · 10b5-1 | 2024-04-08 | 2024-04-08 | $92.33 | $1.2M | -6.4% | -7.9% | -0.5% |
| EW | SELL · 10b5-1 | 2024-03-13 | 2024-03-13 | $91.01 | $1.3M | +0.1% | -3.0% | -6.5% |
| EW | SELL · 10b5-1 | 2024-02-13 | 2024-02-13 | $85.82 | $1.8M | -0.5% | +7.8% | -2.2% |
| EW | SELL · 10b5-1 | 2024-01-12 | 2024-01-12 | $75.67 | $757K | +0.2% | +18.6% | +24.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.